Aminophylline on Perioperative Lung Mechanics in COPD Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 11, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
AminophyllineChronic Obstructive Pulmonary DiseaseObeseLaparoscopic Bariatric SurgeryDexmedetomidineLung Mechanics
Interventions
DRUG

Aminophylline-Dexmedetomidine

10 minutes after endotracheal intubation, patients will receive intravenous (IV) bolus of dexmedetomidine 0.5 microgm/kg Lean body weight (LBW) over 15 min, followed immediately by intravenous infusion at 0.2 microgm /kg LBW/h and IV bolus of aminophylline of 5 mg/kg based on the ideal body weight (IBW) over 30 min, followed immediately by intravenous infusion at 0.6 mg/kg IBW/h. The study solutions will be diluted in 50 ml normal saline.

DRUG

Dexmedetomidine

10 minutes after endotracheal intubation, patients will receive intravenous (IV) bolus of dexmedetomidine 0.5 microgm/kg Lean body weight (LBW) over 15 min, followed immediately by intravenous infusion at 0.2 microgm /kg LBW/h. The study solutions will be diluted in 50 ml normal saline.

Trial Locations (1)

31527

RECRUITING

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER